Mundipharma Appoints Former GSK Exec as Head of Market Access

| By | GSK, Mundipharma
0
79

The Mundipharma network of associated companies has appointed Jerome Moreau to the position of Head of Market Access, reporting to Chris Surridge, European Director of Strategy and Commercial Excellence.

Moreau joins Mundipharma from GSK, where he was Director, Global Market Access and Pricing. His role focused on a global strategy for access and pricing across the COPD franchise and local operating companies.

Before GSK, he worked at Novartis as Senior Expert of Strategic Operations – Market Access & Public Affairs, in France. In this role he led the market access and public affairs strategy plan, launching innovative ‘beyond the pill’ customer solutions with institutional and political stakeholders.

Moreau has over 25 years of experience in biopharma, working in different sales and marketing roles, before progressing into management and business development at leading pharmaceutical companies including Johnson and Johnson.

Commenting on his appointment, Moreau said:

“I am focused on developing the market access function to become a benchmark in the industry and ensuring it is integrated in everything we do. Mundipharma will enable me to deliver this vision and it is the ideal organisation in which to further expand my breadth of experience and passion for patient access.”

Surridge added:

“With a proven track record in the market access arena, Jerome has set out clear goals of how he will help to shape, inspire, and enhance our market access capabilities at Mundipharma.”

SOURCE: pharmafield.co.uk
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.